Study of TP-3654 in Patients With Advanced Solid Tumors

NCT03715504 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: TP-3654

Sponsor

Sumitomo Pharma America, Inc.